Genaro Gutierrez, MD
Interventional Pain Medicine · Austin, TXNPI 1396971826
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.7%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by SPR Therapeutics, Inc at 53.3% of the total. Reporting peaked in 2022 at $35,614 and has fallen 77.8% since, to $7,897 in 2025. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 951 payments — averaging $131.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SPR Therapeutics, Inc$67K
- Boston Scientific$26K
- Abbott$9K
- Si-bone, Inc.$8K
- Nalu Medical, Inc.$5K
- Medtronic$3K
- plus $8K from 32 others
Across 146 payments — averaging $7900.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nalu Medical, Inc.$980K
- SPR Therapeutics, Inc$173K
What the payments were for
- Consulting fees$55,85045%
- Speaking & faculty fees$14,57512%
- Travel & lodging$13,59211%
- Food & beverage$35,89029%
- Education$470%
- Charitable contribution$4,9004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$64,762
- SPECTRA WAVEWRITER$12,621
- iFuse Implant$7,239
- GENERAL - THERAPIES$6,802
- Nalu Neurostimulation System$4,370
- Intracept$2,806
- PROCLAIM$2,271
- Prospera$1,934
- WaveWriter Alpha Prime 16$1,600
- Proclaim IPG$705
- OCTRODE$696
- GENERAL PAIN MANAGEMENT$563
- SYNCHROMEDII$521
- Superion ISS$361
- INTELLIS ADAPTIVESTIM$294
- Stimrouter Implantable Kit$152
- HA MINUTEMAN G3-R$148
- Senza$144
- Omnia$135
- INTELLIS$134
How this compares
$124,855 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 993 | $27,230 |
| BelbucaBuprenorphine Hcl | 16 | $13,051 |
| NucyntaTapentadol Hcl | 14 | $11,897 |
| OxycontinOxycodone Hcl | 19 | $5,977 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 194 | $5,401 |
| Morphine Sulfate ErMorphine Sulfate | 91 | $3,055 |
| Lidocaine | 23 | $3,037 |
| Oxycodone Hcl | 158 | $2,620 |
| Gabapentin | 245 | $2,593 |
| Pregabalin | 122 | $2,345 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $2,327 |
| Morphine Sulfate | 51 | $902 |
| Tizanidine Hcl | 100 | $721 |
| Tramadol Hcl | 110 | $660 |
| Methocarbamol | 41 | $610 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta | $279 | $24,94830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 287 interventional pain medicine providers in Texas.
Other interventional pain medicine in Austin
- Anjuli DesaiAustin$82K
- Paul leAustin$27K
- Martin ThaiAustin$23K
- Clayton AdamsAustin$22K
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.1M
- Chad StephensSouthlake$1M
- Ankur KhoslaShenandoah$277K
- Brian RichDecatur$245K
- Brian BruelHouston$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.